Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Buy
13,347
+1,267
+10% +$138K 0.01% 1143
2026
Q1
$1M Buy
12,080
+2,501
+26% +$214K 0.01% 1296
2025
Q4
$819K Buy
9,579
+572
+6% +$47.8K ﹤0.01% 1330
2025
Q3
$756K Buy
9,007
+1,277
+17% +$117K ﹤0.01% 1218
2025
Q2
$786K Buy
7,730
+797
+11% +$81.3K 0.01% 1106
2025
Q1
$742K Buy
6,933
+4,153
+149% +$430K 0.01% 945
2024
Q4
$308K Buy
+2,780
New +$323K ﹤0.01% 1328

Other funds holding CROX

&Partners's CROX Position: Q2 2026 in Review

&Partners increased its Crocs (CROX) stake by 10% in Q2 2026, buying an estimated $138K and bringing the position to 13,347 shares worth $1.61M. The position accounts for 0.01% of the portfolio, ranked #1143.

&Partners first reported a position in CROX in Q4 2024 and has held it in 7 quarters since. 502 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • &Partners held 13,347 shares of Crocs worth $1.61M as of Q2 2026.
  • &Partners bought 1,267 Crocs shares in Q2 2026, an estimated $138K.
  • Crocs made up 0.01% of &Partners's portfolio in Q2 2026, its #1143 holding.
  • &Partners first reported a position in Crocs in Q4 2024 and has held it in 7 quarters since.
  • 502 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.